350 Enhancing directly selected tumor-reactive TIL function through genetic modification

Antzeko izenburuak

• Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
  nork: Hao Liu, et al.
  Argitaratua: (2016-11-01)
• Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
  nork: Shari Pilon-Thomas, et al.
  Argitaratua: (2023-10-01)
• Nordmenns plikt til å gi
  nork: Jørgen Pedersen
  Argitaratua: (2025-06-01)
• 350 Enhancing directly selected tumor-reactive TIL function through genetic modification
  nork: Christophe Pedros, et al.
  Argitaratua: (2023-11-01)
• 178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy
  nork: Li Liu, et al.
  Argitaratua: (2023-11-01)